{
  "id": 1516827,
  "title": "First-of-its-kind narcolepsy drug opens door to new therapies for the brain",
  "url": "https://urgent.news/2026/08/17/first-of-its-kind-narcolepsy-drug-opens-door-to-new-therapies-for-the",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-17T00:00:00.000Z",
  "source": {
    "name": "Nature",
    "slug": "nature",
    "url": "https://www.nature.com/articles/d41586-026-02552-y"
  },
  "original_language": "en",
  "account": "On a recent occasion, the U.S. Food and Drug Administration granted authorization to the inaugural medicine explicitly crafted to address the underlying cause of narcolepsy, a condition impacting numerous individuals by inducing overwhelming daytime drowsiness and nighttime wakefulness. Local taxes may influence the final cost, determined at the time of purchase.",
  "summary": "Nature, Published online: 17 August 2026; doi:10.1038/d41586-026-02552-y The drug, called Orzeyful, takes aim at the root cause of the sleep disorder rather than at its symptoms.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}